Our staff remains available to you 24/7, offering safe and contactless client services by phone, email and video conference. Learn More!

$650 Million Settlement Reached in MDL Pradaxa Mass Tort Claim

Starting in 2012, cases concerning anticoagulant Pradaxa sprang up rapidly at state and federal levels. Plaintiffs alleged manufacturer Boehringer Ingelheim International GmbH did not provide medical professionals and patients with sufficient information about major risks, such as excessive bleeding from mild trauma and no antidote to hemorrhaging. As of December 2013, 1,963 lawsuits had been…

Read More

Low Testosterone Lawsuit Update: New Side Effects, More Research, MDL Consolidation

Lawsuits concerning low-testosterone supplements have accelerated over the past two months, with more developments surfacing since then. Back in April, a press release from UNT Health Science Center revealed that not only are the supplements like AndroGel associated with increased cardiovascular risks, but they’re also correlated with brain cell damages in certain races. Researchers found…

Read More

New Study Confirms Autism SSRI Link

Although SSRIs assist in improving depressive symptoms, they’re associated with a wide range of side effects, including several birth defects. Past studies have found a link between autism and SSRI exposure in the womb, with another recently finding a similar correlation. Published in Pediatrics on April 14, the study revealed that boys with autism are…

Read More

Danish Study Shows Correlation Between Autism Spectrum Disorders and Valproate Usage

Reported in a July 2013 Everyday Health article, a study performed by the Aarhus University Hospital in Denmark found correlation between valproate use and increased risks of autism. Researchers followed 655,615 women and their children born from 1996 to 2006, observing the group for potential signs of autism and triggers. Data from national registries revealed…

Read More

FDA Targeted Online Pharmacies in Dangerous Drugs Crackdown

From June 18 to June 25, the U.S. Food and Drug Administration unrolled International Operation Pangea VI, an effort as part of the 6th annual International Internet Week of Action that targeted illegal online pharmacies. In conjunction with international regulatory and law enforcement agencies, the FDA targeted 9,600 websites carrying and selling unapproved and dangerous…

Read More